Priority Approval/Registration of Favipiravir Drugs During the COVID-19 Pandemic Ijaz Mustafa COVID-19 July 14, 2020January 18, 2022 Favipiravir_priority-approval_registration-of-drugs-during-the-covid-19-pandemicDownload Share this:TwitterFacebook
